Pubdate: Thu, 12 May 2005
Source: Dover-Sherborn Press (Framingham, MA)
Copyright: 2005 Dover-Sherborn Press
Contact:  http://www2.townonline.com/dover/
Details: http://www.mapinc.org/media/3586
Author: Peter Reuell
Bookmark: http://www.mapinc.org/oxycontin.htm (Oxycontin/Oxycodone)
Bookmark: http://www.mapinc.org/youth.htm (Youth)

AREA TEENS SMITTEN BY OXYCONTIN

Andrew Moskevich doesn't look like a recovering drug addict.

With his close-cropped brown hair and blue eyes, the 21-year-old looks more 
like the prospective college student he is than a former drug-addicted teen 
who forged dozens of checks to support a $400-a-day OxyContin habit.

It's just that averageness that worries Steve Tolman.

The Senate chairman of the state's Joint Committee on Mental Health and 
Substance Abuse, Tolman this week said abuse of prescription drugs like 
OxyContin has exploded among teens and college students. U.S. Rep. Stephen 
Lynch, D-9th, wants to ban the drug outright.

That's how perilous OxyContin abuse has become.

Recent surveys conducted by the state Department of Public found dramatic 
increases in the use of the drug - which users grind up and snort or mix 
with water to inject for a heroin-like high - among 15- to 24-year-olds.

"I consider it a silent epidemic," Tolman said. "They're using this drug, 
probably in a recreational way, thinking it's safe. But when they snort it, 
they become addicted almost immediately."

Raising Awareness

In an effort to raise awareness of the drug's dangers, legislators and 
members of the Massachusetts OxyContin Commission on May 23 will hold a 
hearing on abuse of the drug, and other prescription drugs, at Framingham 
State College.

For most users, though, the drug's cost - an 80-milligram pill costs about 
$80 on the street - quickly becomes prohibitive. As an alternative, many 
turn to heroin, which costs as little as $4 per bag.

It's a story Moskevich is all too familiar with.

By the time he began his freshman year at Peabody High School, he was 
already experimenting with smoking pot, LSD and prescription drugs such as 
Xanax.

It was during the town's International Festival that he first tried 
OxyContin, and he remembers it making him sick. It wasn't until after 
graduating from high school, however, that Moskevich first snorted the 
drug. Within months, he said, he was using regularly.

"I was using, but I wasn't addicted," he said. "It was dangerous in the 
sense that it was leading to something worse ... it was really at the 
crossroads. And then the summer of 2003, it got really crazy."

Career Falters

Instead of going to college, Moskevich took a nursing job, where he 
continued to use the drug to help get through the long, 12-hour shifts. 
Eventually, his drug use was discovered and he was quietly asked to quit.

Without a steady source of income, his addiction took hold, and Moskevich 
turned to forging checks, stealing his father's ATM card and even breaking 
into neighbors' apartments to support his habit.

It wasn't until the day after Christmas two years ago that Moskevich 
finally hit bottom.

After again stealing checks from his father to get high, he gave up, 
eventually checking himself into a detox center, and later moving to the 
Framingham area for a treatment program run by the South Middlesex 
Opportunity Council.

"I think everything happens for a reason," Moskevich said. "I'm grateful, 
as painful as it was, I am very grateful it happened the way it did."

Among many who use the drug, there's no happy ending.

Reports published by the Food and Drug Administration listed OxyContin as 
the "main contributing" factor in 146 overdose deaths in 2002, and the 
"likely contributing" factor in an additional 318 deaths.

New Commission

In an effort to warn the public about the risks of abusing OxyContin and 
other prescription drugs, Waltham Rep. Peter Koutoujian helped form the 
Massachusetts OxyContin Commission.

The commission will hold several hearings over the next several months, 
Koutoujian said, and hopes to produce a report by the fall, which will 
include specific legislative and regulatory recommendations aimed at 
curbing prescription drug abuse.

Part of the reason for the explosion of abuse among teens and college 
students, he believes, is a mistaken belief that "prescription" drugs equal 
"safe" drugs.

"It's legal. It's legally prescribed," he said. "So it's got this [image] 
of being good. It's endorsed by the medical community.

"Two, it's readily available. They say 44 percent of prescription 
medication kids get access to are those used by other family members. When 
you find kids are drinking alcohol, the majority don't go to the liquor 
store to get it, they go to the liquor cabinet. Here they're going to mom 
and dad's medicine cabinet."

It's not just local legislators who are disturbed by the abuse of drugs 
such as OxyContin.

Purdue Pharma, the company that manufactures the drug, has spent more than 
$200 million in an effort to develop drugs that eliminate the high that 
abusers get by crushing the drug, Purdue Director of Public Affairs Jim 
Heins said this week.

"[But] it's not so easy," he said. "If we bring them to market, they not 
only have to be abuse-resistant, but they also have to be safe and 
effective in relieving pain."

Work Done

Besides Purdue, he said, more than a dozen pharmaceutical companies are 
working to develop tamper-resistant drugs.

The company is also working with law enforcement to track potential abusers 
and to educate doctors about the proper uses of the drug, Heins said.

"It's a serious problem," he said. "It's a serious problem for people who 
are abusing it. It's a serious problem for communities, and it's a serious 
problem for patients who need it, because it's a higher barrier.

"There are 50 million people with chronic pain [in the U.S.] Not all are 
candidates for the drug, but there are patients who need relief who are 
either scared because they're misinformed about the risks ... or the 
doctors are saying I'm too afraid of regulatory scrutiny or the media 
coverage, and I'm not going to use these medications."

As for Lynch, there don't seem to be many answers left.

"We've just come to an end point here with the amount of death and 
addictions that have resulted from this one drug," he said this week about 
his federal bill that seeks to pull the drug off the market. "I'm really at 
wit's end to find a way to stop this."
- ---
MAP posted-by: Beth